Denosumab improves bone mineral density and microarchitecture in rheumatoid arthritis: randomized controlled trial by HR-pQCT
ConclusionDenosumab may be recommended for patients with RA treated with csDMARDs to increase BMD and improve bone microarchitecture.
Source: Journal of Bone and Mineral Metabolism - Category: Orthopaedics Source Type: research
More News: Arthritis | CT Scan | DEXA Scan | Orthopaedics | Osteoporosis | Rheumatoid Arthritis | Rheumatology | Study | Xgeva